FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ponder, K. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ponder, K. P.

The FASEB Journal, Vol 10, 673-682, Copyright © 1996 by The Federation of American Societies for Experimental Biology

REVIEWS

Analysis of liver development, regeneration, and carcinogenesis by genetic marking studies

KP Ponder
Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

The mechanism of generating new hepatocytes and bile ductule cells in the liver has been controversial. Oval cells are found in the periportal region under some circumstances and may represent multipotent stem cells. The role of stem cells in generating new liver cells in normal and pathological conditions is unclear, however. Genetic marking can be used to determine the ability of a particular cell to replicate and to migrate. Cells of known lineage are marked at an initial time point, and their developmental potential determined by the cluster size, position, and phenotype of marked cells at a later time point. Recently, genetic marking studies have demonstrated that the hepatocyte itself is the source of new hepatocytes in the normal postnatal liver and that daughter cells do not migrate. These studies have also demonstrated that the hepatocyte can replicate extensively when stimulated. Finally, genetic marking studies suggest that either hepatocytes or oval cells can develop into a hepatocellular carcinoma or cholangiocarcinoma if a sufficient number of genetic mutations accumulate. The implications of these results for hepatic gene therapy, treatment of liver insufficiency states, and liver cancer are discussed. Future genetic marking studies may help to address some remaining questions in liver biology.


This article has been cited by other articles:


Home page
 BloodHome page
L. Xu, C. Gao, M. S. Sands, S.-R. Cai, T. C. Nichols, D. A. Bellinger, R. A. Raymer, S. McCorquodale, and K. P. Ponder
Neonatal or hepatocyte growth factor-potentiated adult gene therapy with a retroviral vector results in therapeutic levels of canine factor IX for hemophilia B
Blood, May 15, 2003; 101(10): 3924 - 3932.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Imai, M. Jiang, P. Kastner, P. Chambon, and D. Metzger
Selective ablation of retinoid X receptor alpha in hepatocytes impairs their lifespan and regenerative capacity
PNAS, March 29, 2001; (2001) 71056098.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Z. Dong, X. Wang, Q. Zhao, C. M. Townsend Jr., and B. M. Evers
DNA methylation contributes to expression of the human neurotensin/neuromedin N gene
Am J Physiol Gastrointest Liver Physiol, March 1, 1998; 274(3): G535 - G543.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Imai, M. Jiang, P. Kastner, P. Chambon, and D. Metzger
Selective ablation of retinoid X receptor alpha in hepatocytes impairs their lifespan and regenerative capacity
PNAS, April 10, 2001; 98(8): 4581 - 4586.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by The Federation of American Societies for Experimental Biology.